Fabry disease: open trials in South Korea

• NCT00196742

  Fabry Disease Registry & Pregnancy Sub-registry

  Research · Genzyme, a Sanofi Company

  Busan · Daejeon · Jeju City · Seoul · Seoul · Seoul · Seoul · Seoul · Seoul · Seoul · Suwon · Yangsan · Yangsan · Yangsan

  Registry updated 2026-10-14

• NCT07235709

  Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study

  Research · Yonsei University

  Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul

  Registry updated 2025-12-01

• NCT06858397

  A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

  Trial Treatment · Phase 1/2 · GC Biopharma Corp

  Yonsei University College of Medicine, Seoul · Pusan National University Children's Hospital in Yangsan, Yangsan

  Registry updated 2025-11-04

All Fabry disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error